109 research outputs found
Façade retrofitting: from energy efficiency to climate change mitigation
Abstract Since climate changes are now evident, it is not only important to achieve high level of energy efficiency, but also to think about retrofit actions in order to mitigate the natural hazard impacts and to make buildings resilient. The paper focuses on climate change effects in summer and investigates how it is possible to reduce them through facade retrofitting solutions (external insulation, PCM, green wall, cool materials) in Mediterranean climate. The goal is to develop a set of climatic resilience indicators for opaque envelopes in order to consider resilience ability against climate change, both inside and outside of buildings
School Building Heritage: Energy Efficiency, Thermal and Lighting Comfort Evaluation Via Virtual Tour
Abstract Since the Italian school buildings cause huge energy waste, it is increasingly compelling to identify, quantify and eliminate energy deficits through integrated audits and coordinated actions of energy saving and retrofit. We developed a methodology that is based on a holistic approach that correlates students' post occupancy evaluation with instrumental survey and software simulations and, at the same time, we examined an innovative use of virtual tour to make the energy audit results friendly available to school managers and community. This methodology, validated on a school building of the 20s-30s, identified energy saving and retrofitting actions according to cost levels
A practical approach to the use of low molecular weight heparins in VTE treatment and prophylaxis in children and newborns.
Low-molecular weight heparins are currently the most commonly used anticoagulants in children and newborns. However, since thrombotic complications rarely occur outside large children’s hospitals, physicians often encounter some practical problems inmanaging these treatments when a pediatric thrombosis specialist is not available. The drug of choice is enoxaparin, due to its favorable FXa/FIIa ratio and the availability of pharmacokinetic and pharmacodynamic data. The treatment of acute thrombosis should be started with two daily injections but when compliance is an issue, a single daily administration schedule could be chosen for secondary prophylaxis ensuring careful measurement of the post 24-hour anti-FXa activity. Furthermore, a subcutaneous device may be a useful tool and a topical dermal anesthetic could be effective in controlling pain without affecting anti-FXa levels. In neonate and toddlers, where mini doses are frequently needed, the dead space of syringes and needles could represent an issue and therefore the use of insulin syringes without dead space is advisable,while a dilution of the drug is useful with other syringes.
This article derives froma nonsystematic review of the available literature, with special attention to recent international guidelines and expert recommendations, combined to authors’ clinical practice in large tertiary pediatric hospitals and will provide concise and practical information for the use of low-molecular weight heparin in childhood and infancy in a sort of “answering frequently asked questions.
The risk of venipuncture in newborn with severe hemophilia: Case report of a large elbow hemorrhage and literature review of compartment syndrome
Hemophilias are hemorrhagic congenital rare diseases. The gold standard of therapy in hemophilics is the intravenously replacement therapy. We can infuse intravenously plasma derived factors (FVIII for Hemophilia A and FIX for Hemophilia B) or recombinant products (i.e. clotting factor synthetically produced). Venipuncture is not a safe procedure in subjects with hemorrhagic diseases. It is considered an invasive technique with potential massive bleeding and it requires standardized procedures to prevent complications. Local pressure after the procedure (with eventually ice rest) must be always done. In case of bleeding a rapid replacement therapy must be conducted. A severe complication in hemophilia is compartment syndrome. We report a case of massive bleeding in a hemophilic newborn after venipuncture and a literature review of compartment syndrome in hemophiliacs. The aim of this paper is to help physicians in the clinical management to prevent the evolution of a massive bleeding in compartment syndrome
Non-alcoholic fatty liver disease is associated with early left ventricular dysfunction in childhood acute lymphoblastic leukaemia survivors.
Background: Childhood acute lymphoblastic leukaemia (ALL) survivors have an increased risk of metabolic and
cardiovascular disease. We aimed to assess the presence of non-alcoholic fatty liver disease (NAFLD) in childhood ALL
and if it is associated with early cardiovascular dysfunction.
Methods: In total, 53 childhood ALL survivors and 34 controls underwent auxological evaluation, biochemical assay,
liver, heart and vascular ultrasound study.
Results: NAFLD was more frequent in ALL patients than in controls (39.6% vs 11.7%, P < 0.01). Patients with NAFLD
were more obese and insulin resistant than patients without NAFLD. Flow-mediated dilatation and interventricular
septum were lower in the ALL group than those in the control group (P < 0.001 for both). The patients with NAFLD
showed lower left ventricular ejection fraction than those without NAFLD (P = 0.011). In ALL survivors, BMI-SDS and
subcutaneous fat were the strongest predictors of NAFLD, whereas preperitoneal adipose tissue and C-reactive protein
were the strongest predictors of left ventricular ejection fraction.
Conclusions: Childhood ALL survivors had higher prevalence of NAFLD than healthy controls, which is associated
with early left ventricular impairment. In the case of fatty liver, a comprehensive heart evaluation is mandatory. We
strongly recommend to prevent visceral adiposity in ALL survivors, to search for metabolic
syndrome or its components and to reinforce the need of intervention on diet and lifestyle
during the follow-up of these patients
A Narrative Approach to Describe QoL in Children With Chronic ITP
Objective: Primary immune thrombocytopenia (ITP) is a hemorrhagic disorder. Spontaneous recovery within 12 months occurs in the majority of pediatric patients. Nevertheless, in 20–30% of children the disease is chronic. The impact extends to the patients' families, whose everyday life, in terms of interpersonal relationships and financial status, is adversely affected. This study investigated the ability of a narrative instrument to improve the quality of life of pediatric chronic ITP patients and their families and quantified the familial burden imposed by the illness.Method: A quantitative survey and a narrative plot delivered through an online platform were adopted for the analysis.Results: Pediatricians of ten Italian Hematologic Centers explained the projects to patients and their family in the outpatient clinic. 70 caregivers of children with ITP filled the ad-hoc questionnaire. Data from 53 caregivers revealed the emotional impact of pediatric chronic ITP. The narrative approach highlighted the specific resources used by patients and their families to cope with the disease and its chronicity.Discussion: Caregivers underlined the need for “humaneness” in their interactions with clinical personnel. The majority of respondents provided positive feedback regarding the narrative project, defining the experience as “liberating” and improving their quality of life
Substrate reduction therapy with Miglustat in pediatric patients with GM1 type 2 gangliosidosis delays neurological involvement: A multicenter experience
n/
Clinical Features, Cardiovascular Risk Profile, and Therapeutic Trajectories of Patients with Type 2 Diabetes Candidate for Oral Semaglutide Therapy in the Italian Specialist Care
Introduction: This study aimed to address therapeutic inertia in the management of type 2 diabetes (T2D) by investigating the potential of early treatment with oral semaglutide. Methods: A cross-sectional survey was conducted between October 2021 and April 2022 among specialists treating individuals with T2D. A scientific committee designed a data collection form covering demographics, cardiovascular risk, glucose control metrics, ongoing therapies, and physician judgments on treatment appropriateness. Participants completed anonymous patient questionnaires reflecting routine clinical encounters. The preferred therapeutic regimen for each patient was also identified. Results: The analysis was conducted on 4449 patients initiating oral semaglutide. The population had a relatively short disease duration (42%  60% of patients, and more often than sitagliptin or empagliflozin. Conclusion: The study supports the potential of early implementation of oral semaglutide as a strategy to overcome therapeutic inertia and enhance T2D management
- …